Henry Schein (HSIC) reported $3.17 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 0.1%. EPS of $1.15 for the same period compares to $1.10 a year ago.
The reported revenue represents a surprise of -1.84% over the Zacks Consensus Estimate of $3.23 billion. With the consensus EPS estimate being $1.11, the EPS surprise was +3.60%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Henry Schein performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Geographic Revenue- International- Dental Equipment: $197 million compared to the $209.20 million average estimate based on four analysts.
- Geographic Revenue- U.S. Distribution- Dental- Equipment: $187 million versus the four-analyst average estimate of $232.79 million.
- Geographic Revenue- International- Dental Merchandise: $594 million compared to the $608.26 million average estimate based on four analysts.
- Geographic Revenue- International- Medical: $25 million versus $27.96 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -7.4% change.
- Geographic Revenue- U.S. Distribution- Dental: $823 million versus $854.49 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -25.4% change.
- Geographic Revenue- U.S. Distribution- Medical: $1.03 billion compared to the $1.01 billion average estimate based on four analysts. The reported number represents a change of +1.6% year over year.
- Geographic Revenue- International- Dental: $798 million versus the four-analyst average estimate of $824.47 million. The reported number represents a year-over-year change of -1.6%.
- Geographic Revenue- U.S. Distribution- Dental- Merchandise: $591 million compared to the $569.68 million average estimate based on four analysts.
- Net sales- Eliminations: -$37 million versus -$38.92 million estimated by six analysts on average.
- Net sales- Global Specialty Products: $367 million compared to the $364.59 million average estimate based on six analysts.
Shares of Henry Schein have returned -0.3% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Only $1 to See All Zacks' Buys and Sells
We're not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
See Stocks Now >>Henry Schein, Inc. (HSIC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
